Technetium Therapeutics
An AI-Driven Hatchery of Novel Medicines
Technetium Therapeutics is harnessing the power of advanced AI technology to transform the future of oncology and immunology in human medicine.
About Us
Pioneering AI-Driven Drug Discovery
Technetium Therapeutics is at the forefront of utilizing advanced artificial intelligence (AI) to accelerate drug discovery.
Our mission is to discover and optimize novel lead therapeutic compounds that will revolutionize the treatment of oncological and immunological diseases. Using our innovative AI workflow, we streamline the drug design process and thereby improve both speed and success in discovering new therapeutic molecules.
Our Platform
Our AI Agentic Workflow
Our proprietary TechnetiumX AI agentic workflow, an iterative system that combines state-of-the-art AI models with human expert input, is at the core of our approach.
This AI agent enables the development of novel, therapeutic small molecules based on target and design constraints.
This AI agent evaluates AI-proposed drug molecules and sends feedback to the design agent.
Targeted Diseases
Our pipeline focuses on two primary areas
Oncology
We are targeting various types of cancer by discovering molecules that inhibit the growth of various tumors.
Immunology
We are developing treatments that modulate the immune system to enable control of autoimmune diseases and boosting of immune defenses in chronic conditions.
Get in touch
Don't hesitate to contact us.
We’d love to hear from you! Whether you’re interested in learning more about our AI-driven drug discovery process, exploring partnership opportunities, or have any other inquiries, feel free to reach out.
- info@technetiumtx.com
Revolutionizing drug discovery with advanced AI to develop life-saving treatments for oncology and immunology diseases.